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Abstract
In the human genome, susceptibility to common diseases is likely to be determined by interactions between multiple
genetic variants. We propose an innovative Bayesian method to tackle the challenging problem of multi-locus pattern
selection in the case of quantitative phenotypes. For the first time, in this domain, a whole Bayesian theoretical frame-
work has been defined to incorporate additional transcriptomic knowledge. Thus we fully integrate the relationships
between phenotypes, transcripts (messenger RNAs) and genotypes. Within this framework, the relationship between
the genetic variants and the quantitative phenotype is modeled through a multivariate linear model. The posterior
distribution on the parameter space can not be estimated through direct calculus. Therefore we design an algorithm
based on Markov Chain Monte Carlo (MCMC) methods. In our case, the number of putative transcripts involved in
the disease is unknown. Moreover, this dimension parameter is not fixed. To cope with trans-dimensional moves, our
sampler is designed as a reversible jump MCMC (RJMCMC). In this document, we establish the whole theoretical
background necessary to design this specific RJMCMC.
Introduction
In the hunt for genes affecting our health and wellbeing, association studies look for associations between
genetic features and phenotypes such as health / illness. Many common diseases in humans are suspected
to be caused by complex epistatic interactions among multiple genes. In the literature, different accep-
tations are encountered for the term epistasis [4]. In this paper, epistasis is defined for a set of genetic
loci as the situation arising when not all loci, and possibly none at all, have a main effect on the disease,
whereas the combination of the loci causes the disease. Marginal epistatic interactions have been iden-
tified for diseases such as coronary heart disease [21], breast cancer [24], Alzheimer’s disease [38] and
Crohn’s disease [30].
The last decade has witnessed an explosion in the number of research works aiming at tackling epis-
tasis identification. Amongst deterministic approaches, we mention SNPRuler, a branch and bound algo-
rithm devoted to the expansion of sets of SNPs in the binary phenotype case [33]. This method describes
the relationship between the epistatic SNPs and the phenotype through a predictive rule. A measurement
of rule relevance is deduced from the χ-square statistic. A rule is grown if the added SNP increases the
relevance. Specific properties of this measure, as well as the possibility to calculate an upper bound,
allow to traverse the space of predictive rules without exhaustive search. Central to software TEAM [36]
is the speeding up of contingency table (CT) computation through a true structure. This method restrains
to two-SNP epistasis and tests such as the χ-square test. Given the CTs of two single SNPs and the CT
for genotype relation between these two SNPs, only little effort is required to compute the two-locus CT.
The CT for genotype relation between the two SNPs is inferred from a minimum spanning tree built on
the SNPs. Therein, each edge represents the genotype difference between the two connected SNPs.
Supervised learning algorithms include standard regression methods as well as stepwise approaches.
Least square or maximal likelihood estimations are the rule for quantitative (continuous) phenotypes. Lo-
gistic regression (or binomial regression) is devoted to binary phenotypes (affected/unaffected status). In
logistic regression, parameter estimation maximizes the likelihood and usually relies on Markov Chain
Monte Carlo (MCMC) sampling strategies for this purpose. Some approaches combine forward stepwise
procedure and logistic regression [16, 22]. Logic regression attempts to identify boolean combinations
of SNPs for the prediction of the affected/unaffected status of an observation. The logic expressions are
represented by logic trees. Permissible moves in the tree-growing process are alternating an operator
or a variable, pruning or growing a branch, and adding or removing variables. To find the best models,
stochastic algorithms are applied, such as simulated annealing [26] or MCMC [25]. As a matter of fact,
in the former work, simulated annealing is applied to different subsets of the data. Dealing with binary
phenotypes, Symbolic Discriminant Analysis (SDA) may be viewed as an extension of both linear and
logic regression approaches [18]. In SDA, the data dictates the size, shape and complexity of a symbolic
function, discriminant for case/control status. The symbolic function combines mathematical functions
from a list provided by the user. Genetic programming is used to optimize the discriminant power of the
models [17].
Non-parametric data mining strategies have been investigated. Besides standard forest-based ap-
proaches [3], random forests combine bagging with random selection of features (see MegaSNPHunter
[32], for example). In bagging - or bootstrap aggregating - a few hundred to a few thousand classification
or decision trees are generated from as many bootstrap samples drawn from the available data. Multifac-
tor dimensionality reduction (MDR) applies an exhaustive search to pool genotypes from combinations of
SNPs [9]. Thus, data dimension is reduced to one, with two genotype pools accumulating either affected
or unaffected subjects. When the phenotype is continuous, pooling is achieved through a combinatorial
partition of the genotypes [35]. In the previous Combinatorial Partitioning Method (CPM), for each com-
6bination of SNPs, the partitions are exhaustively enumerated and tested for discriminating power. The
Restricted Partition Method (RPM) is a heuristic which guides the straightforward construction of the best
possible partition, per each combination of SNPs [6]. RPM implements ascending hierarchical clustering
for this purpose.
Probabilistic graphical models were also used to search for causal SNP combinations. In an approach
based on Markov random field models [31], the graph structure connects cliques of (pairwise) dependent
SNPs with the phenotype node. An MCMC strategy samples over the space of possible graphs, with a
restriction on physical distance between any two markers in a clique. The MCMC strategy samples from
the posterior distribution of graphs conditional on the data. Only MCMC moves towards decomposable
graphs are allowed, to allow an easy computation of marginal likelihood. A novel framework, forests
of hierarchical latent class models, was introduced to handle high-dimensional data [19]. To learn the
model, an ascending hierarchical clustering first discovers cliques of dependent SNPs, subsume them
through additional (latent) variables if possible, then iterates the previous two steps on the latent variables
and remaining SNPs.
Bayesian approaches relying on MCMC strategies have been investigated to search the space of SNP
combinations. The BEAM [37] and epiMODE [29] programs implement a Bayesian marker partitioning
model to identify candidate combinations, together with MCMC computation of the posterior probability
that each candidate combination is associated with the disease. The BAMSE algorithm explores sets of
effects (SNPs and environmental factors) that increase the risk (binary phenotype) or the phenotypic value
(quantitative phenotype), for individuals who fulfill the criterion defined by the set [1].
Several reviews provide coverage of recent algorithm developments in the research domain around
epistasy (see for instance [11, 20, 12, 27, 15]. The subject is hot topic and advanced methods are con-
stantly proposed to attempt to tease associations out of datasets. For instance, some leads are incorporat-
ing data imputation to an association study (AS) process [10] or integrating gene expression data (GED)
[13]. In particular, there was still room for investigating a Bayesian method based on GED integration.
We propose a novel approach based on transcriptomic and genetic data integration, to tackle AS under the
multigenic hypothesis. The genetic data considered are Single Nucleotide Polymorphisms (SNPs) and we
only address continuous phenotypes in the present work. Downstream specific analyses, whose purpose
is relating phenotypes to transcripts and genetic markers to gene expression data (and thus to transcripts),
our procedure explores the search space consisting of SNP sets - or multi-locus patterns (MLPs) -. Such
MLPs are as many candidates for phenotype explanation. Crossing phenotype/GED associations and
GED/MLP associations into phenotype/GED/MLP associations is the final objective or our approach.
However, since we address multigenic etiology, any such MLP may be covered by a set of transcripts - a
transcript pattern (TP) -, on the genome. Thus, we can replace the previous scheme phenotype/GED/MLP
with phenotype/TP/MLPs, where each transcript in the TP is co-located with one of the MLPs. Thus, we
avoid a fine-grained description of MLPs, and escape the expensive search in the space of MLPs. The
core idea of our proposal lies in that the SNP search space is connected to TP subspaces, which allows a
coarse-grained MLP description. As we do not constrain the number of transcripts potentially involved
in the disease etiology, we have to explore TP subspaces of various dimensions.
Besides, the linear regression model has often proven useful to describe the relationships between
SNPs and continuous phenotype. Indeed, regression-based tests are current tools offered by the soft-
ware suites dedicated to genome-wide association studies, such as the PLINK software toolbox ([23],
http://pngu.mgh.harvard.edu/ purcell/plink/), the Golden Helix SNP & variation suite (http://www.golden
helix.com), the snpMatrix R package [7] distributed as part of the BioCond uctor project (http://www.bioconductor.org).
Mixing three ingredients - Bayesian framework, transcriptomic / genetic data integration, linear model, -
7we have designed an innovative approach. Within this framework, the relationship between the genetic
variants and the quantitative phenotype is modeled through a multivariate linear model. Then, to only
focus on parts of the posterior distribution that are of interest on the large parameter space, we have con-
ceived an algorithm based on Markov Chain Monte Carlo (MCMC) methods. In our case, the number
of putative transcripts involved in the disease is unknown. Furthermore, this dimension parameter is not
fixed. Therefore, to cope with trans-dimensional moves in the MCMC, our sampler is designed as a re-
versible jump MCMC (RJMCMC).
Our contribution in this report is twofold. We describe a whole Bayesian theoretical framework meant
to integrate transcriptomic and genetic data for genetic association purpose. We describe the RJMCMC
designed to perform the Bayesian computation. In particular, we provide here the theoretical background
and derive the corresponding calculuses necessary to the implementation of our algorithm.
The first Section states the problem and gives the nomenclature necessary to describe the search
space, for our specific case. Section 2 provides a gentle introduction to readers not familiar with MCMCs
and RJMCMCs. The third Section introduces our framework. It first presents the moves allowed in
our MCMC approach. Then it shows how transcriptomic and genotypic data are integrated through a
multivariate linear model. This section ends with a sketch of the algorithm. The next section is devoted
to the derivation of the posterior parameter distribution.
1 Premiminaries
1.1 Statement of the problem
We consider τ quantitative phenotypes - or targets -. Our aim is to identify potentially causal epistatic
SNPs, in order to explain each target. Since we address multigenic etiology, we consider that any such
causal set of SNPs may be covered by a set of transcripts - a transcript pattern -, on the genome. The
problem we tackle arises downstream two series of studies: through a previous approach, relations be-
tween genetic markers and transcripts have been derived; besides, for any such transcript, associations
with MLPs have been investigated. A solution to our problem assigns a TP to each target and an MLP to
each transcript in the TP. This assignment has to best explain the determinism of the MLPs assigned to
each target, on this target. No a priori is provided, regarding the sizes of TPs.
1.2 Notations and definitions
In the following, since we deal with transcripts that are co-located with SNPs, these transcripts will be
referred to as co-mRNAs. The search space S to be explored is a set of solutions each assigning a set of
active co-mRNAs to each target, together with an active MLP per each such active co-mRNA. A solution -
or a state of the RJMCMC - is described through its parameters, η. Most of the constituents of η, together
with their domains of variation, are described in Table 1), and illustrated by Figure 1.
2 A short introduction to Markov Chain Monte Carlo methods and
reversible jump MCMCs
Here, we first provide a brief introduction to MCMCs. Then, we justify the construction of RJMCMCs
and show how the theoretical framework is adapted to take into account trans-dimensional moves.
An ergodic (aperiodic and irreducible) Markov chain will converge towards a unique stationary dis-
tribution, π. Markov Chain Monte Carlo (MCMC) methods are a class of algorithms designed to sample
8T , | T |= τ set of τ targets (or quantitative phenotypes)
Ci, | Ci |= qi,
∑
i∈T q
i = q set of all qi possible co-mRNAs known to potentially exert an impact on target i
Ci, | Ci |= si the set of si active co-mRNAs for target i, in current JRMCMC state
k =
∑
i∈T s
i the number of active co-mRNAs over all targets
M j , |M j |= mj the set of all possible multi-locus patterns for co-mRNA j
Mi the set of all active multi-locus patterns for target i
Mi = [uj1 , uj2 , · · · , ujsi ]
ziℓ =| Miℓ |=| ujℓ | size of the multi-locus pattern Miℓ of target i, corresponding to active co-mRNA ℓ
Table 1: Nomenclature for parameter space description
from a desired probability distribution: their principle consists in constructing a Markov chain that has the
desired distribution as its stationary distribution. Given an ergodic Markov chain, and p, the probabilities
of transition from state to state in search space S (transition kernel), the property of reversibility between
states x and y holds: π(s) p(s′ | s) = π(s′) p(s | s′) (detailed balance equation). Though reversibility
is not necessary to guarantee convergence of the posterior to π, it is sufficient. Then, the key to MCMC
consists in expressing the transition kernel p(s′ | s) as the product of an arbitrary proposal distribution,
q, and an associated acceptance distribution, a: p(s′ | s) = q(s′ | s) a(s, s′). To explain the intuition
behind these concepts, suppose, without loss of generality, that for states s and s′, some given transition
kernel p verifies π(s) p(s′ | s) > π(s′) p(s | s′). Artificial coercion of the previous formula towards
reversibility is straightforward, introducing two terms a(s, s′), strictly lower than 1, and a(s′, s), equal
to 1: π(s) q(s′ | s) a(s, s′) = π(s′) q(s | s′) a(s′, s). If inequality is reversed, then a(s′, s), strictly
greater than 1, and a(s, s′), equal to 1, will be used instead. Finally, acceptance probability is calculated
as: a(s, s′) = min
(
1, π(s′) q(s′,s)π(s) q(s,s′)
)
. The arbitrary proposal distribution q and the acceptance probability
a are the two ingredients of the Metropolis-Hastings (MH) algorithm (see Algorithm 1).
Algorithm 1 Metropolis-Hastings
1: initialize state X0 arbitrarily; i← 0
2: repeat until convergence
3: propose next value Xi+1 = y from the proposal distribution q(. | Xi = x).
4: sample uniformly u in interval [0, 1]
5: if (u ≤ a(x, y)) then Xi+1 ← y /* acceptance of proposed move */
6: else Xi+1 ← x /* rejection of proposed transition */
7: incr(i)
8: end repeat
When the search space writes as S =
{
(k, θ(k)), k ∈ K, θ(k)) ∈ Sk
}
, where K is an enumerable set,
then the posterior distribution can be factorized as π(θ(k), k) = π(θ(k) | k) π(k). To impose reversibility
for each pair (θ(k1)1 ), θ
(k2)
2 ), the core idea is to supplement each of the corresponding sub-spaces Sk1 and
Sk2 with adequate artificial spaces. Namely, θk1 and θk2 will be completed into (θk1 , u1) and (θk2 , u2),
respectively. Sampling u1 and u2 from adequate distributions g1 and g2 will guarantee the existence of a
bijection fk1,k2 between the augmented sub-spaces corresponding to Sk1 and Sk2 . Under this condition,
the acceptance probability now involves the product of four terms:
a(θ
(k1)
1 , θ
(k2)
2 ) = min
{
1,
π(θ(k2), k2)
π(θ(k1), k1)
p(k1 | k2)
p(k2 | k1)
q(u2 | k2, θ(k2))
q(u1 | k1, θ(k1))
Jfk1 ,k2
}
, (1)
9Figure 1: Illustration for definitions in Table 1. τ = 2; left section of the Figure shows possible co-
mRNAs and multi-locus patterns: q = 5; C1 = {1, 2, 3}, C2 = {4, 5}; M1 = {1, 2}, M2 = {3, 4, 5},
M3 = {6}, M4 = {7, 8, 9}, M5 = {10, 11} - right section displays an MCMC state with its active
co-mRNAs and its active multi-locus patterns: k = 4; C1 = {2, 3}, C2 = {4, 5}; M1 = {3, 6},
M2 = {8, 11}; z1,3 = 3, z1,6 = 2, z2,8 = 2, z2,11 = 1. X1 to X8 denote random variables involved in
the models describing the relationships between Y 1 and Y 2 (random variables associated with targets 1
and 2, respectively).
where p(k2 | k1) denotes the probability of the dimensionality switch and q(u1 | k1, θ(k1)) refers to the
probability of transition θ(k1) → θ(k2). In some cases, including ours, the Jacobian Jfk1 ,k2 is equal to
1. Therefore, in these cases, the acceptance probability may be seen as the product of two terms: the
posterior ratio distribution (π(θ(k2),k2)
π(θ(k1),k1)
) and the sub-product p(k1|k2)p(k2|k1)
q(u2|k2,θ
(k2))
q(u1|k1,θ(k1))
, which is called the
proposal ratio. In this case, the role of all these ingredients is made explicit in the generic description of
an iteration of the reversible jump MCMC algorithm (RJMCMC) (see Algorithm 2).
3 The RJMCMC framework
3.1 Description of the five moves
To explore S, we allow five moves: addition of an active co-mRNA (A), dismissing of an active co-
mRNA (D), substitution for an active co-mRNA (C), substitution for an active MLP (M), modification of
the regression coefficients (R). Move A and move D respectively add and dismiss an entry in both lists
C and M. Move C updates an entry in both lists C and M. Move D only updates an entry in list M.
Figure 2 starts from the MCMC state depicted in Figure 1, to describe moves A, D, S and M. Clearly, the
MCMC will possibly traverse subsets of the search space characterized by different values of parameter
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Algorithm 2 Generic description of an iteration in the RJMCMC algorithm
1: current state is Xi = θ(k1) in sub-space Sk1
2: draw u1 from q(. | k1, θ(k1))
3: calculate θ(k2) using bijection fk1,k2 : (θ(k2), u2) = fk1,k2(θ(k1), u1) /* θ(k2) is the value proposed
for next state Xi+1 */
4: sample uniformly u in interval [0, 1] and apply lines 5 and 6 of Algorithm 1 with the acceptance
probability calculated in Equation 1.
k, the number of active co-mRNAs over all targets. Thus, we have to deal with the trans-dimensional
case.
Figure 2: Moves of the MCMC
3.2 The underlying model linking phenotypes to causal multi-locus patterns via
co-mRNA patterns
The data consist in τ quantitative phenotypes (or targets), (yi)i∈T and an array of genetic markers x.
These date describe p individuals. Random variables are defined accordingly: Y i, defined over R, for
target i, and X iℓt (categorical, defined on domain {0, 1, 2}, i ∈ T , 1 ≤ ℓ ≤ si, 1 ≤ t ≤ ziℓ; individuals
in rows, SNPs in columns). Our hypothesis is that of a multivariate linear model:
Y i = ai0+
∑
1≤ℓ≤si,1≤t≤ziℓ a
iℓtX iℓt+ εi, with εi following a normal distribution (εi ∼ N (0, σi)).
In the previous formula, i denotes a target, ℓ an active co-mRNA of target i, and t the tth SNP in the cur-
rent active MLP of active co-mRNA ℓ. The predictors X iℓ1 · · ·X iℓzM
iℓ
correspond to the SNPs in active
MLP Miℓ. The (complete) putative causal MLP consists of MLPs Mi1 Mi2 ... Misi . For example, in
Figure 1, the two current linear regression models respectively describe the relationship between Y 1 and
X1 · · ·X5, and between Y 2 and X6 · · ·X8.
We now introduce a convenient notation to refer to the matrix of regression coefficients associated
with ith target:
Notation 3.1 Regression coefficients aXi
The predictor set X i associated with target i has size
∑si
ℓ=1 z
iℓ
. The whole set of regression coefficients
is then:
ai = aXi = (a
i0, (aiℓt)1≤t≤ziℓ) (2)
Thus, a state in our RJMCMC is fully described through parameter η = (k, s, C,M, z,X, a, σ).
3.3 Outline of the algorithm
The sketch of the method is depicted in Algorithm 3.
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Algorithm 3 RJMCMC
INPUT:
x, a matrix describing p subjects (rows) with regard to e genetic markers (columns).
x
j
i is a categorical value (genotype code) (1 ≤ i ≤ p; 1 ≤ j ≤ e)
y, a matrix describing τ targets (rows), with regard to the p subjects (columns)
y
j
i is a quantitative continuous value
For each target i, Mi is the set of mRNAs hypothesized to exert an influence on target i.
For each mRNA i, Ci is a set of multi-loci patterns co-localized with co-mRNA i.
A multi-loci pattern is a set of genetic markers.
OUTPUT:
For each target i,Mi, the most frequent set of active multi-loci patterns encountered during stationary regime of
the RJMCMC.
1: Initialization: (k, s, C,M, z,X, a, σ)← (k0, s0, C0,M0, z0,X0, a0, σ0)
2:
3: do
4: sample u ∼ U[0,1] /* uniform draw in interval [0,1] */
5: switch
6: u < ak: proposeMoveA /* add-active-co-mRNA */
7: ak ≤ u < ak + dk: proposeMoveD /* Delete-active-co-mRNA */
8: ak + dk ≤ u < ak + dk + ck: proposeMoveC /* Substitute-active-co-mRNA */
9: ak + dk + ck ≤ u < ak + dk + ck + mk: proposeMoveM /* Substitute-active-multi-locus-pattern */
10: else moveR /* change of regression coefficients for all active multi-locus patterns */
11: /* associated with all active co-mRNAs */
12: end switch
13: until (convergence)
Moves A to M occur with respective probabilities ak, dk, ck and mk, depending on k, the current
number of active co-mRNAs over all targets. Probabilities ck and mk indirectly depend on k since ak
and dk are evaluated as follows:
ak = c min(1,
pk¯(k + 1)
pk¯(k)
), dk = c min(1,
pk¯(k − 1)
pk¯(k)
), (3)
where k is assumed to follow an a priori truncated Poisson distribution with mean λ, in the line of
multiple changepoint approaches involving reversible jump MCMC [8, 28]:
pk¯(k) ∝
λk
k!
1{k≤k¯}. (4)
Depending on c value adjustment and balance between ck and mk, we can state than some moves are
more often proposed than others. Hyperparameter λ is updated at each iteration of the MCMC. Following
[2], λ is sampled as follows:
k ∼ N (
1
2
+ k + ε1, 1 + ε2), (5)
with εi << 1, (i = 1, 2).
Except for move R, the feasibility of a move is subject to the satisfaction of various constraints (see
Table 2):
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move constraints
A ak¯ = 0, aq¯ = 0
D d0 = 0
Each target must appear in any proposed solution with at least one active co-
mRNA. Thus, the active co-mRNA proposed for dismissing must be checked
to be associated with a target currently showing a number of active co-mRNAs
strictly greater than 1.
C The co-mRNA proposed for replacing an already active co-mRNA is necessar-
ily associated with a target checking the following constraint: the number of
possible co-mRNAs must be strictly greater than the number of current active
co-mRNAs.
M The active co-mRNA concerned by the replacement of its current active multi-
loci pattern must be checked to possess at least one more possible multi-loci
pattern.
Table 2: Constraints involved in the calculation of move probabilities. k¯: maximal value allowed for k;
q, maximal number of possible co-mRNAs, over all targets.
4 Space parameter posterior distribution
For all moves except move R, the acceptance probability must first be evaluated, to further validate or
reject the move from current state η to proposed state η′. Andrieu and Doucet’s works pionnered the
theoretical construction of an RJMCMC based on a multivariate linear model [2]. In their founder ap-
proach, the parameter description includes, quite classically, a variance parameter, and more specifically,
regression coefficients. These authors have shown that in the evaluation of the acceptance probability, the
Jacobian term is equal to 1.
In the expression
αη,η′ = min(1, rη,η′ )
= min(1, posterior distribution ratio× proposal ratio)
= min
(
1,
p(η
′
| y)
p(η | y)
× proposal ratio
)
,
(6)
we now focus on posterior distribution ratio ( p(η
′
|y)
p(η|y) ), where y represents the data, that is the pheno-
types, in our case. To evaluate the posterior distribution ratio, we have to derive an algebraical expression
for p(ζ | y).
Indeed, we will not deal with p(η
′
|y)
p(η|y) , but instead with
p(ζ
′
|y)
p(ζ|y) . It is crucial to distinguish that in the
full description of the MCMC state η:
η = (k, s, C,M, z,X, a, σ) = (ζ, a, σ),
parameters a and σ are not assigned a status identical to that of other parameters. Our guidelines,
the works of Andrieu and Doucet, have established that we are allowed to carry out the integration of the
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so-called ”nuisance parameters” a and σ in expression p(η | y), to obtain an expression for p(ζ | y). Thus
we will consider a move proposal without previously generating parameters a (and σ, in the case of move
A) for the modified target. To be rigorous, we will now write aζ,ζ′ and rζ,ζ′ instead of aη,η′ and rη,η′ .
To reach our objective, calculate p(ζ | y), we will implement the six steps recapitulated in Table 3.
(1) To render explicit p(η | y), use Bayes theorem and write p(η | y) ∝ p(y | η) p(η).
(2) evaluate p(η).
(3) evaluate p(y | η).
(4) substitute the expressions obtained in steps (2) and (3) for the corresponding terms in p(y |
η)× p(η) and obtain a first algebraic formula for p(y | η).
(5) transform p(y | η) into a formula more appropriate for integration.
(6) perform marginalization over the nuisance parameters a and σ, that is, eliminate a and σ from
p(η | y), through integration, to obtain the posterior distribution p(ζ | y).
Table 3: The six steps necessary to derive the parameter posterior distribution.
4.1 Step 1 - Use of Bayes formula to render explicit the posterior distribution
To render explicit p(η | y), we use Bayes theorem, p(η | y) p(y) = p(y | η) p(η), to write
p(η | y) ∝ p(y | η) p(η), (7)
that is posterior distribution = likelihood× prior.
The constant p(y) will be ignored since rη,η′ deals with a ratio of posterior probabilities.
4.2 Step 2 - Analytical formulation of prior p(η)
p(η) = p(k, s, C,M, z,X, a, σ)
= p(k) p(C | k) p(s | k, C)
∏
i∈T
p(zi, X i, ai, σi,Mi | Ci) (8)
In Equality 8, the term p(s | k, C) is fully determined. We recall that the total number k of co-
mRNAs (all targets considered) is assumed to follow an a priori Poisson distribution with mean λ (see
Expression 4). Conditional on number k, the vector C of (active) co-mRNAs is drawn with the following
prior uniform distribution:
p(C | k) =
1
CkP
i∈T q
i
=
1
Ckq
. (9)
As s is fully determined conditional on k and C, probability p(s | k, C) is equal to 1.
We now concentrate on the evaluation of the term
∏
i∈T p(z
i, X i, ai, σi,Mi | Ci):
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Y
i∈T
p(zi,Xi, ai, σi,Mi | Ci) (10)
=
Y
i∈T
siY
l=1
p(ziℓ, Xiℓ, aiℓ, σiℓ,Miℓ | Ciℓ)
=
Y
i∈T
siY
l=1
p(ziℓ, Xiℓ, aiℓ | σiℓ,Miℓ, Ciℓ) p(σiℓ)
=
Y
i∈T
siY
l=1
p(Xiℓ | Ciℓ) p(ziℓ | Xiℓ) p(aiℓ | ziℓ,Xiℓ, σiℓ) p(σiℓ). (11)
First right-hand term p(X iℓ | Ciℓ) follows a uniform distribution ( 1
mCiℓ
). Second right-hand term,
p(ziℓ | X iℓ) is equal to 1 since X iℓ fully determines ziℓ (ziℓ =| X iℓ |). Expression 10 is more conve-
niently written as:
Y
i∈T
p(zi,Xi, ai, σi,Mi | Ci) =
Y
i∈T
p(ai | zi,Xi, σi) p(σi)
0
@Y
i∈T
siY
l=1
1
mC
iℓ
1
A . (12)
Expression 12 exhibits the two terms p(ai | zi, X i, σi) and p(σi). To propose priors for ai and σi,
we rely on the specific scheme proposed by Andrieu and Doucet. In their precursor works on RJMCMCs
based on a multivariate linear model, the regression coefficients are assumed to follow a Gaussian distri-
bution, conditional on predictor set X i. Before we give the Gaussian distribution, we need the following
definitions:
Definition 4.1
Given X i, the whole set of predictors associated with target i, DXi(x) is the matrix defined over
{0, 1, 2}, of dimension p ×
(
(
∑si
ℓ=1 z
iℓ) + 1
)
, where p is the number of subjects observed. First
column is a vector of 1s while each cell DXi(x)o,j+1 describes jthregressor of set X i, for subject o. We
define matrix ΣXi as: ΣXi−1 = DTXi(x) DXi(x).
Definition 4.2
ΣXi = D
T
Xi(x) DXi(x). (13)
Under the zero-mean Gaussian assumption with covariance (σi)2 ΣXi , we write:
p(ai | zi, X i, σi) =| 2π(σi)
2
ΣXi |
−1/2 exp
(
−
aTXiΣ
−1
XiaXi
2(σi)2
)
. (14)
Regarding scale parameter σi, as p(σi) and p(σi)2 are equal, the prior distribution of variable (σi)2
is given instead. (σi)2 is assumed to follow a conjugate inverse-Gamma law:
(σi)
2
∼ IG(υ0/2, γ0/2). (15)
Andrieu and Doucet recommend to choose (υ0/2, γ0/2) = (0, 0), to obtain Jeffrey’s uninformative
prior p((σi)2) ∝ 1(σi)2 .
Thanks to equations 8, 4, 9, 12, 15 and 14, expression p(η) is now entirely explicit.
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4.3 Step 3 - Analytical formulation of likelihood p(y | η)
The likelihood is expressed as:
p(y | η) =
∏
i∈T
p(yi | η). (16)
Since a linear model is assumed (yi−DXi(x) aXi = εi), we now state that the noise εi is zero-mean
Gaussian with variance (σi)2:
p(yi | η) =
1
(2π (σi)2)p/2
exp
[
−
(yi −DXi(x) aXi)
T (yi −DXi(x) aXi)
2(σi)
2
]
. (17)
4.4 Step 4 - Temporary algebraic expression for posterior distribution p(η | y)
Combining the explicit derivations for p(η) (see step 2, Equality8) and p(y | η) (see step 3, Equalities
16 and 17) in Equality 7, we obtain a temporary algebraical expression of the joint posterior distribution
p(η | y):
p(η | y) ∝
λk
k!
1
Ckq
0
@Y
i∈T
siY
l=1
1
mC
iℓ
1
A
Y
i∈T
| 2π(σi)
2
ΣXi |
−1/2 exp
"
−
aT
Xi
Σ−1
Xi
aXi
2(σi)2
#
γ0
2
υ0
2
Γ(υ0
2
)
((σi)2)
−
υ0
2
−1
exp
"
−
γ0
2
(σi)2
#
1
(2π (σi)2)p/2
exp
"
−
(yi DXi (x) aXi)
T (yi DXi(x) aXi )
2(σi)2
#
. (18)
However, the obtained expression does not straightforwardly lend itself to integration with respect to
a and σ parameters.
4.5 Step 5 - Definite algebraic expression for posterior distribution p(η | y)
Before we perform the integration process, we need to transform Equality 18 into a more appropriate
algebraic expression. The transformation process applied by Adrieu and Doucet in their work on the
detection of noisy sinusoidal signals was not much detailed. However, three clues allowed us to derive
again the transformation process. The three clues consisted of three definitions, which were as many
starting points to guess the derivation. In our specific case, these definitions write:
P i = I −DXi(x) M
i DTXi(x) (19)
M i =
δ2
δ2 + 1
(DTXi(x) DXi(x))
−1 (20)
di = M i DTXi(x) y
i. (21)
Appendix 1 reports the steps of the process providing the final expression to be marginalized:
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p(η | y) ∝
λk
k!
1
Ckq
0
@Y
i∈T
siY
l=1
1
mC
iℓ
1
A
Y
i∈T
(
| 2π(σi)
2
ΣXi |
−1/2 exp
"
−
(aXi − d
i)T (M i)
−1
(aXi − d
i)
2(σi)2
#
exp
"
−
γ0 + (yi)
T
Pyi
2(σi)2
#
(σi
2
)−
υ0
2
−1− p
2
)
.
(22)
4.6 Step 6 - Integration of the nuisance parameters
The expression obtained for p(η | y) through step 5 is now convenient for elimination of a and σ pa-
rameters. From the expression of p(η | y), we will thus obtain an expression of the posterior distribution
p(ζ | y). In this case, the nuisance parameters can be eliminated on a theoretical basis, through integral
calculus. Note that the MCMC is not used for this purpose.
Appendix 2 details the integration process. Finally, we obtain:
p(ζ | y) ∝
λk
k!
1
Ckq

∏
i∈T
si∏
l=1
1
mCiℓ


[
(γ02 )
υ0
2
Γ(υ02 )
Γ(
υ0 + p
2
)
]τ
1
(2π)
τp
2
∏
i∈T
P(target i),
with P(target i) =
(
γ0 + (y
i)
T
P iyi
2
)− υ0+p2
. (23)
5 Calculation of acceptance probabilities
5.1 Addition of a co-mRNA (move A)
At line 4 in Algorithm 4, the drawn multi-loci pattern will determine the set of predictors to be added
to the current predictor set of some target i∗, if move A is further accepted (see line 7). In line 9, the
new co-mRNA ℓ∗ is taken into account (k+ = k + 1; si∗+ = si∗ + 1; Ci∗+ = Ci∗ ⊕ ℓ∗; Mi∗+ =
Mi∗⊕m∗); zi∗ℓ∗
+
=| Mi∗ℓ∗ |), where⊕ designates the appending operation and m∗ is the new multi-
locus pattern. The predictor set X i∗+ is computed as X i∗ augmented with the variables corresponding to
the SNPs of m∗. The set of regression coefficients ai∗ is augmented accordingly, to yield ai∗+.
The acceptance probability for move A is:
α(ζ, ζ+) = min(1, r(ζ, ζ+)), where r(ζ, ζ+) (indeed rk,k+1(ζ, ζ+)) writes as:
r(ζ, ζ+) =
p(ζ+ | y)
p(ζ | y)
dk+1
ak
q(ζ | ζ+)
q(ζ+ | ζ)
. (24)
Following Equation 23, the terms appearing in r(ζ, ζ+) are respectively evaluated as:
p(ζ+ | y) =
λk+1
(k + 1)!
1
Ck+1q

∏
i∈τ
si∏
ℓ=1
1
mCiℓ

 P(target i, co-mRNA ℓ∗,multi-loci pattern m∗) (25)
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Algorithm 4 proposeMoveA
1: if (q − k > 0)
2: propose a new co-mRNA ℓ∗ uniformly drawn in the q − k current non active co-mRNAs.
3: /* The drawn co-mRNA corresponds to a given target i∗ */
4: propose a multi-loci pattern m∗ uniformly drawn in M i∗ℓ∗
5: compute αζ,ζ+
6: sample u ∼ U[0,1]
7: if (u ≤ αζ,ζ+ )
8: sample σi∗+ and ai∗+
9: modify the Markov chain state into (k + 1, s+, C+,M+, z+,X+, a+, σ+)
10: else
11: keep the chain in state (k, s, C,M, z,X, a, σ)
12: end if
13: end if
p(ζ | y) =
λk
k!
1
Ckq

∏
i∈τ
si∏
ℓ=1
1
mCiℓ

 P(target i). (26)
From Equalities 25 and 26, we derive the posterior distribution ratio:
p(ζ+|y)
p(ζ|y) =
λ
q−k
1
mi∗ℓ∗
P(target i∗,transcript ℓ∗,multi-locus pattern m∗)
P(target i*) .
The first term in the proposal ratio, dk+1ak
q(ζ|ζ+)
q(ζ+|ζ) , simplifies in:
dk+1
ak
=
k + 1
λ
, (27)
whereas the second term is calculated as shown below.
Given k − q, the total number of inactive co-mRNAs over all targets, we easily derive:
q(ζ+ | ζ) =
1
q − k
. (28)
However, the calculation of q(ζ | ζ+) is not so straighforward; it involves that of term qd(ζ+):
q(ζ | ζ+) =
1
qd(ζ+)
, (29)
referring to definition 5.1.
Definition 5.1 For state ζ, qd(ζ) is the number of active co-mRNAs, over all targets showing a number
of active co-mRNAs strictly greater than 1.
qd(ζ
+) is derived from qd(ζ). Figure 3 shows how qd decreases by one from state ζ+ to state ζ, on a
simple case. Nevertheless, another (unique) case has to be considered, as depicted in Figure 4: therein,
the active co-mRNA of state ζ+, whose dismissing yields state ζ, is one of the two active co-mRNAs of
a target. This entails that the remaining active co-mRNA of this target can no more contribute to qd(ζ)
calculation. Thus, the following property holds:
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Property 5.1
qd(ζ
+) =
{
qd(ζ) + 2 if the co-mRNA is added to a target with only one active co-mRNA
qd(ζ) + 1 otherwise.
Figure 3: Increase of qd between states ζ and ζ+, in a simple case. See text, Definition 5.1. A and B
denote targets. q: number of possible co-mRNAs over all targets; k: number of active co-mRNAs over
all targets; q = 7; k(ζ) = 3; k(ζ+) = 4; qd(ζ) = 2; qd(ζ+) = 3.
From Equalities 28 and 29, the second term in the proposal ratio writes as:
q(ζ | ζ+)
q(ζ+ | ζ)
=
q − k
qd(ζ+)
. (30)
Finally, in Equation 24 we substitute the expressions respectively obtained in 5.1, 27 and 30, respec-
tively for posterior distribution ratio, first and second terms of proposal ratio. Therefore, the definite
formula derived for r(ζ, ζ+) is the following:
r(ζ, ζ+) =
k + 1
qd(ζ+)
1
miℓ∗
P(target i∗, co-mRNA ℓ∗,multi-locus pattern m∗)
P(target i*)
. (31)
In move A, parameter a has to be sampled. This sampling depends on parameter σ. Finally, both
parameters are sampled. From equation 22, it can be easily derived that:
(σi)
2
| yiζ ∼ IG(
υ0 + p
2
,
γ0 + y
iT P yi)
2
(32)
and
aXi | y
i, ζ, σi ∼ N (M i DTXi y
i, (σi)
2
M i). (33)
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Figure 4: Increase of qd between states ζ and ζ+, in the unique alternative of the case presented Figure 3.
q = 7; k(ζ) = 2; k(ζ+) = 3; qd(ζ) = 0; qd(ζ+) = 2.
5.2 Deletion of a co-mRNA (move D)
Quite symmetrically with respect to move A, denoting i∗ the target for which a co-mRNA ℓ∗ is dismissed,
and using Equation 31, we obtain:
r(ζ, ζ−) = rk,k−1(ζ, ζ
−) =
`
rk−1,k(ζ
−, ζ)
´−1
=
qd(ζ)
k
miℓ∗
P(target i)
P(target i∗, co-mRNA ℓ∗,multi-locus pattern m∗)
, (34)
where m∗ denotes the active multi-locus pattern associated with co-mRNA ℓ∗. The pseudo-code of this
move is depicted in Algorithm 5.
Algorithm 5 proposeMoveD
1: if (qd(ζ) > 0)
2: propose a co-mRNA ℓ∗ uniformly drawn amongst the qd(ζ) current active co-mRNAs.
3: /* The drawn co-mRNA corresponds to a given target i∗ */
4: compute αζ,ζ−
5: sample u ∼ U[0,1]
6: if (u ≤ αζ,ζ− )
7: sample ai∗−
8: modify the Markov chain state into (k − 1, s−, C−,M−, z−,X−, a−, σ)
9: else
10: keep the chain in state (k, s, C,M, z,X, a, σ)
11: end if
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5.3 Substitution of a co-mRNA (Move C)
Move C implements the replacement of an active co-mRNA ℓ with another active co-mRNA ℓ∗, for
a given target i∗. m is the active multi-locus pattern associated with replaced co-mRNA ℓ, while m∗
denotes the active multi-locus pattern associated with replacing co-mRNA ℓ∗. Move C is typically a
Metropolis update, meaning that the term r(ζ, ζ∗), indeed rk(ζ, ζ∗), merely writes as follows:
r(ζ, ζ∗) =
p(ζ∗ | y)
p(ζ | y)
q(ζ | ζ∗)
q(ζ∗ | ζ)
. (35)
From Equation 23, the posterior distribution ratio is easily derived in:
p(ζ∗ | y)
p(ζ | y)
=
miℓ
mi∗ℓ∗
P(target i, co-mRNA ℓ∗,multi-locus pattern m∗)
P(target i∗, co-mRNA ℓ,multi-locus pattern m) . (36)
To evaluate the terms involved in the proposal ratio ( q(ζ|ζ∗)q(ζ∗|ζ) ), we need define a new term, qc:
Definition 5.2 For state ζ, qc(ζ) is the number of active co-mRNAs, over all targets showing a number
of possible co-mRNAs strictly greater than their number of active co-mRNAs.
In other terms, each such target t is characterized by qt − st > 0.
This definition entails the following property:
Property 5.2 Since each target must always present at least one active co-mRNA in any state, move C
only concerns a target t possessing at least two possible co-mRNAs (qt > 1).
To calculate q(ζ∗ | ζ), we first have to uniformly draw the replaced active co-mRNA amongst the
qc(ζ) co-mRNAs allowed. Now knowing the target i∗ which is subject to the replacement of one of its
active co-mRNAs (ℓ), we uniformly draw the replacing active co-mRNA amongst qi∗(ζ) − si∗(ζ) valid
candidates. Therefore, the denominator of the proposal ratio (q(ζ∗ | ζ)) writes as:
q(ζ∗ | ζ) =
1
qc(ζ)
1
qi∗(ζ) − si∗(ζ)
. (37)
Similarly, the numerator of the proposal ratio expresses as:
q(ζ | ζ∗) =
1
qc(ζ∗)
1
qi∗(ζ∗)− si∗(ζ∗)
. (38)
The strong constraint implied by Property 5.2 indicates that there are not many cases to be studied to
establish the straightforward relationship between qc(ζ) and qc(ζ∗):
Property 5.3 qc(ζ∗) = qc(ζ).
Figure 5 allows a quick understanding of Property 5.3.
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Figure 5: Relationship between qc(ζ) and qc(ζ∗), for states ζ and ζ∗, corresponding to move C, unique
possible case. See text, Definition 5.2 and Property 5.2. A, B, C and D denote targets. q: number of
possible co-mRNAs over all targets; k: number of active co-mRNAs over all targets; q = 10; k(ζ) =
k(ζ∗) = 7; qc(ζ) = qc(ζ∗) = 3.
Besides, in the case of move C, si∗(ζ∗) and si∗(ζ) are equal. Together with Property 5.3, this equality
entails that:
q(ζ | ζ∗)
q(ζ∗ | ζ)
= 1. (39)
Therefore, using Equation 36, r(ζ, ζ∗) is merely computed as:
r(ζ, ζ∗) =
p(ζ∗ | y)
p(ζ | y)
. (40)
The scheme of this move is depicted in Algorithm 6. At line 2, the replaced co-mRNA is determined
(ℓ). ℓ determines a target i. Conditional on target i, a replacing co-mRNA is drawn at line 4. Conditional
on the target and the replacing co-mRNA, a multi-locus pattern is drawn at random (m∗). If the move
is accepted (see line 8), the set of predictors corresponding to this multi-locus pattern will be added
to the current predictor set of target i. The set of predictors corresponding to the replaced co-mRNA
will be dismissed from target i’s predictors. In line 10, the co-mRNA substitution from ℓ into ℓ∗ is
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acknowledged: Ci∗ = Ci ⊖ ℓ ⊕ ℓ∗; Mi∗ = Mi ⊖m⊕m∗); ziℓ∗∗ =| Miℓ∗ |). Operation ⊖ performs
the deletion operation on a vector. m is the multi-locus pattern associated with replaced co-mRNA ℓ,
whereas m∗ refers to the multi-locus pattern connected to the replacing co-mRNA. The predictor set X i∗
is computed as X i dismissed of the variables corresponding to the SNPs in m, and further augmented
with the variables corresponding to the SNPs in m∗. The set of regression coefficients ai is accordingly
updated into ai∗.
Algorithm 6 proposeMoveC
1: if (qc(ζ) > 0)
2: propose a replaced co-mRNA ℓ uniformly drawn in the qc(ζ) current active co-mRNAs
3: /* The drawn co-mRNA corresponds to a given target i */
4: propose a replacing co-mRNA iℓ∗ uniformy drawn in the qi − si non active co-mRNAs of target i
5: propose a multi-locus pattern uniformly uniformly drawn in M iℓ∗
6: compute αζ,ζ′
7: sample u ∼ U[0,1]
8: if (u ≤ αζ,ζ′ )
9: sample aiℓ∗
10: modify the Markov chain state into (k, s, C∗,M∗, z∗,X∗, a∗, σ∗)
11: else
12: keep the chain in state (k, s, C,M, z,X, a, σ)
13: end if
14: end if
5.4 Substitution of a multi-locus pattern
Again a Metropolis update, move M replaces the active multi-locus pattern m associated with an active
co-mRNA ℓ of, say, target i. The co-mRNA ℓ remains active while the MCMC evolves from state ζ to
state ζ∗. The only difference between both states lies in that multi-locus pattern m∗ now replaces m.
The term r(ζ, ζ∗) is defined as in Equation 36. Therein, since miℓ and miℓ∗ are obviously equal
(ℓ∗ = ℓ), the posterior distribution ratio now simplifies to:
p(ζ∗ | y)
p(ζ | y)
=
P(target i, co-mRNA ℓ,multi-locus pattern m∗)
P(target i, co-mRNA ℓ,multi-locus pattern m) . (41)
The calculation of proposal ratio ( q(ζ|ζ∗)q(ζ∗|ζ) ) requires a new definition:
Definition 5.3 For state ζ, qm(ζ) is the number of active co-mRNAs, over all targets showing a number
of possible multi-locus patterns strictly greater than 1.
In other terms, each such co-mRNA r, associated with, say, target t, is characterized by mtr > 1.
Given this new definition, the denominator of the proposal ratio straighforwardly writes as:
q(ζ∗ | ζ) =
1
qm(ζ)
1
miℓ(ζ) − 1
. (42)
The first term in Equation 42 coerces the choice of the active multi-locus pattern to be replaced: a
uniform draw amongst the qm(ζ) co-mRNAs allowed ensures the satisfaction of the required constraint.
Now knowing that active co-mRNA ℓ associated with target i is concerned by move M, the replacing
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co-mRNA is uniformly drawn amongst the miℓ − 1 valid candidates. Indeed, Definition 5.3 guarantees
that m is not the unique multi-locus pattern possible for co-mRNA ℓ.
It is obvious that qm(ζ∗) and qm(ζ) are equal. Therefore, the proposal ratio simplifies to 1 and as for
move C, r(ζ, ζ∗) is expressed as in Equation 40. This time, r(ζ, ζ∗) will be computed using Equation 41.
This move is described in Algorithm 7.
At line 2, as in move C, an active co-mRNA is drawn at random amongst the qm(ζ) co-mRNAs
allowed. Then, at line 4, conditional on target i and active co-mRNA ℓ∗, a multi-locus pattern is uniformly
drawn. If this latter candidate, say m∗ is accepted (see line 7), the set of predictors described by this
multi-locus pattern will replace the current contribution of active co-mRNA ℓ∗, in the predictor set of
target i. Line 9 akcnowledges this multi-locus pattern substitution: the predictor set X i∗ is computed as
X i dismissed of the variables corresponding to m, subsequently augmented with the variables associated
with the replacing multi-locus pattern, m∗. The set of regression coefficients ai is updated accordingly.
Algorithm 7 Substitute-multi-locus-pattern
1: if (qm(ζ) > 0)
2: propose co-mRNA i ∗ ℓ uniformly drawn in the qm(ζ) current active co-mRNAs
3: /* The drawn co-mRNA corresponds to a given target i∗ */
4: propose a replacing multi-loci pattern i ∗ ℓ ∗ m∗ uniformy drawn in the (mC
i∗ℓ∗
− 1) non active multi-loci
patterns of active co-mRNA i ∗ ℓ∗
5: compute αζ,ζ′
6: sample u ∼ U[0,1]
7: if (u ≤ αζ,ζ′ )
8: sample ai∗ℓ∗
9: modify the Markov chain state into (k, s, C
′
,M
′
, z
′
,X
′
, a
′
, σ
′
)
10: else
11: keep the chain in state (k, s, C,M, z,X, a, σ)
12: end if
13: end if
5.5 Modification of the regression coefficients (Move R)
The last move proposed is the modification of the regression coefficients. It is simultaneously performed
for all targets.
The reversible jump MCMC presented here can be viewed as implementing three levels. The first
level (moves A and D) entails a variation of parameter k. As an MH update of the Markov chain (k
unchanged), move C still lies in the scope of first level since it entails a substitution for co-mRNAs.
Again an MH update, move M introduces the second level of our RJMCMC: this finer level only deals
with multi-locus patterns. Third level restrains to the change of regression coefficients. When dealing
with multivariate linear models, only two-step RJMCMCs had been proposed before [2, 14]. In this
latter case, the updating of the linear model is fine-grained and the addition or dismissing of a (single)
predictor is performed in the second (inner) level. In contrast, our approach modifies the structure of the
linear model in the two upper levels. In the third level, for every target i in turn, move R updates σi and
the whole set of regression coefficients aXi , relying on the two distributions given in 43 and 44. These
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distributions are derived from Equation 22.
(σi)
2
| yi, ζ ∼ IG(
υ0 + p
2
,
γ0 + y
iT P yi
2
) (43)
aXi | y
i, ζ, σi ∼ N (M i DXi
T yi, (σi)
2
M i). (44)
Algorithm 8 describes move R.
Algorithm 8 moveR
1: for each target i
2: update σi
3: update ai
4: end for
5: end for
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Appendix 1 - Transformation of the algebraic expression of the pos-
terior distribution
Given the three matrices
P i = I −DXi(x)M
i DXi(x)
T , M i = (DXi (x)
T DXi(x))
−1
, di = M i DXi(x)
T yi,
the transformation of
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requires that the following equality be true:
aT
Xi
Σ−1aXi + (y
i −DXi(x)aXi )
T (yi −DXi(x) aXi) = (aXi − d
i)T (M i)−1(aXi − d
i) + yi
T
P i yi. (45)
In the sequel, for lisibility, we will drop the indexes:
aTΣ−1a + (y −Da)T (y −Da) = (a − d)TM−1(a − d) + yT P y.
We now derive the equality:
(a− d)T M−1 (a− d) + yT P y
=(a−M DT y)T DT D (a−M DT y) + yT P y
=(aT − yT DMT )DT D (a−M DT y) + yT (I −D (DT D)−1 DT ) y
=aT DT D a− aT DT D M DT y − yT D MT DT D a+ yT DMT DT DM DT y + yT y − yT D (DTD)−1 DT y
=aT DT D a− aT DT D (DTD)−1 DT y − yT D ((DT D)−1)T DT D a+ yT D ((DT D)−1)T DT D (DT D)−1 DT y + yT y − yT D (DTD
=aT DT D a− aT DT y − yT D ((DT D)T )−1 DT D a+ yT D ((DTD)T )−1 DT D (DTD)−1 DT y + yT y − yT D (DTD)−1 DT y
=aT DT D a− aT DT y − yT D (DT D)−1 DT D a+ yT D (DT D)−1 DT D (DT D)−1 DT y + yT y − yT D (DTD)−1 DT y
=aT DT D a− aT DT y − yT D a+ yT D (DT D)−1 DT y + yT y − yT D (DT D)−1 DT y
=aT DT D a− aT DT y − yT D a+ yT y.
We recall that in Section 4.2, we defined ΣXi :
29
ΣXi = D
T
Xi(x) DXi(x).
More, concisely, this writes: Σ = DT D.
Thus, we derive
(a − d)T M−1 (a− d) + yT P y
=aT Σ−1 a + aT DT D a − aT DT y − yT D a + yT y
=aT Σ−1 a + (aT DT − yT )D a + (yT − aT DT ) y
=aT Σ−1 a + (y −Da)T (y −Da)2.
30
Appendix 2 - Marginalization over nuisance parameters a and σ
In formula 22 od Section 4.5, we identify two expressions related to two well-known probability density
functions: that of a multidimensional normal distribution (for parameter ai) and that of an inverse gamma
distribution (for parameter (σi)2). Therefore, marginalization over the nuisance parameters is straight-
forward, through integral calculus. The probability density function of the multidimensional distribution
of parameters (di, (σi)2M i) appears. Integrating on parameter ai provides 1.
The inverse gamma distribution of parameters (α,β) is:
IG(α, β) =
βα
Γ(α)
z−α−1 exp(
β
z
).
In formula 22, we recognise z−α−1 exp(βz ),
where z = (σi)2, α = υ0+p2 , β =
γ0+y
iT P i yi
2 . Integrating z
−α−1 exp(βz ) on the domain of
variation of z yields Γ(α)βα ,
in our case: Γ(
υ0+p
2 )„
γ0+(y
i)T Pi yi
2
« υ0+p
2
.
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Bayesian multi-locus pattern selection and
computation through reversible jump MCMC
Christine Sinoquet
Abstract
In the human genome, susceptibility to common diseases is likely to be determined by interactions between multiple
genetic variants. We propose an innovative Bayesian method to tackle the challenging problem of multi-locus pattern
selection in the case of quantitative phenotypes. For the first time, in this domain, a whole Bayesian theoretical frame-
work has been defined to incorporate additional transcriptomic knowledge. Thus we fully integrate the relationships
between phenotypes, transcripts (messenger RNAs) and genotypes. Within this framework, the relationship between
the genetic variants and the quantitative phenotype is modeled through a multivariate linear model. The posterior
distribution on the parameter space can not be estimated through direct calculus. Therefore we design an algorithm
based on Markov Chain Monte Carlo (MCMC) methods. In our case, the number of putative transcripts involved in
the disease is unknown. Moreover, this dimension parameter is not fixed. To cope with trans-dimensional moves, our
sampler is designed as a reversible jump MCMC (RJMCMC). In this document, we establish the whole theoretical
background necessary to design this specific RJMCMC.
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